Consistently, another study also revealed that the CD8+ T-cell response to tumor-associated antigens was diminished in both STING-deficient and IRF3-deficient mice [35]; these data suggest that host-cell STING and IRF3 are required for spontaneous CD8+ T-cell activity against immunogenic tumors. The gene discussed is IRF3; the disease is neoplasm.